The loop diuretic bumetanide appears to improve some of the core behavioral symptoms of autism by decreasing levels of the neurotransmitters gamma-aminobutyric acid (GABA), new research suggests.

Future Cardiol. 2012;8(5):707-728. These data come from reports of ototoxicity of 6.4% with furosemide compared with 1 and <1% for bumetanide and torsemide, respectively. [38] Acute kidney failure is ...

CHICAGO -- A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared with oral and intravenous delivery in a phase I trial of ...

CHICAGO, IL—A novel way of taking the loop diuretic bumetanide—by nasal spray—is safe and well tolerated in healthy adults, according to preliminary randomized data. Diuretic concentrations achieved ...

PRAGUE, Czechia—The number of people taking loop diuretics without a diagnosis of heart failure (HF) may be many times higher than the number of HF patients on these meds, according to an analysis of ...

Credit: Aptar Pharma. Enbumyst is supplied in a unit-dose nasal spray containing bumetanide 0.5mg per 0.1mL. Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon ...

Loop diuretics are commonly prescribed to older adults to induce diuresis in fluid-overload states, such as congestive heart failure, and to treat hypertension; however, these agents increase urinary ...

Enbumyst is not intended for chronic use and should be replaced with oral diuretics as soon as practical. The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of ...